Pages that link to "Q36733271"
Jump to navigation
Jump to search
The following pages link to Narcolepsy with cataplexy (Q36733271):
Displaying 50 items.
- Stimulant drugs for narcolepsy in adults (Q24188240) (← links)
- Antidepressant drugs for narcolepsy (Q24242527) (← links)
- Effects of Modafinil on the Sleep EEG Depend on Val158Met Genotype of COMT (Q24602466) (← links)
- Neurophysiology of sleep and wakefulness: basic science and clinical implications (Q24658243) (← links)
- A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis (Q26776231) (← links)
- Unmet needs of patients with narcolepsy: perspectives on emerging treatment options (Q26827736) (← links)
- Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis (Q26865413) (← links)
- REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology (Q27013653) (← links)
- H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice (Q27317087) (← links)
- Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9 (Q27345325) (← links)
- Sleep Paralysis in Brazilian Folklore and Other Cultures: A Brief Review (Q28074876) (← links)
- Pharmacotherapy options for cataplexy (Q28287690) (← links)
- Non-dipping blood pressure profile in narcolepsy with cataplexy (Q28480931) (← links)
- Executive control of attention in narcolepsy (Q28482920) (← links)
- Differences in brain morphological findings between narcolepsy with and without cataplexy (Q28535473) (← links)
- AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland (Q28730881) (← links)
- Predictive models of glucose control: roles for glucose-sensing neurones (Q30208992) (← links)
- Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. (Q30352315) (← links)
- Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. (Q30362783) (← links)
- Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. (Q30367259) (← links)
- A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden. (Q30376157) (← links)
- Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies (Q30376727) (← links)
- Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy (Q30402238) (← links)
- Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland (Q30414919) (← links)
- A physiologically based model of orexinergic stabilization of sleep and wake (Q30441208) (← links)
- Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice (Q30498843) (← links)
- Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling (Q30499169) (← links)
- Orexin neurons suppress narcolepsy via 2 distinct efferent pathways (Q30569775) (← links)
- Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation (Q30582000) (← links)
- Neuroimaging findings in narcolepsy with cataplexy. (Q30606609) (← links)
- CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. (Q30818202) (← links)
- The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures (Q33157223) (← links)
- Cataplexy and Its Mimics: Clinical Recognition and Management (Q33168590) (← links)
- Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients (Q33685660) (← links)
- Increased immune complexes of hypocretin autoantibodies in narcolepsy (Q33725437) (← links)
- Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy. (Q33737141) (← links)
- Hypocretin/orexin and narcolepsy: new basic and clinical insights (Q33814590) (← links)
- Low vitamin D in narcolepsy with cataplexy. (Q33919832) (← links)
- From phenomenology to neurophysiological understanding of hallucinations in children and adolescents (Q34077221) (← links)
- miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias (Q34125869) (← links)
- Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders (Q34126143) (← links)
- Histamine in the regulation of wakefulness (Q34138704) (← links)
- Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns (Q34144175) (← links)
- Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study (Q34267735) (← links)
- The startle syndromes: physiology and treatment (Q34311939) (← links)
- Genetic association, seasonal infections and autoimmune basis of narcolepsy (Q34333298) (← links)
- A unifying computational framework for stability and flexibility of arousal (Q34369364) (← links)
- Decision making in narcolepsy with cataplexy (Q34405585) (← links)
- Sleep disorders, obesity, and aging: the role of orexin (Q34451399) (← links)
- Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy (Q34500458) (← links)